Travel Vaccine Leadership Leverage Valneva's market-leading travel vaccines to pursue new distribution partnerships with travel clinics, hospital networks, and corporate health programs in Europe and North America to boost uptake and revenue.

Lyme Collaboration The Pfizer-partnered Lyme disease vaccine candidate offers a pathway for co-development funding, manufacturing scale-up, or regional licensing deals to accelerate global commercialization.

Manufacturing Capacity Valneva's vaccine manufacturing capabilities across multiple countries present a strong basis for contract manufacturing or fill-finish partnerships with other developers seeking scale and reliability.

Strategic Financing With cash-conscious guidance and pending regulatory steps, pursue milestone-driven partnerships or co-development arrangements to fund the pipeline and reduce near-term cash burn.

Global Distribution A multi-country footprint creates opportunities for regional distribution agreements with public health agencies and distributors in Europe, the United States, and Canada for existing travel vaccines and future candidates.